financetom
Business
financetom
/
Business
/
General Mills' Fiscal Q1 Adjusted Earnings, Net Sales Decline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
General Mills' Fiscal Q1 Adjusted Earnings, Net Sales Decline
Sep 22, 2024 12:05 PM

07:24 AM EDT, 09/18/2024 (MT Newswires) -- General Mills ( GIS ) reported fiscal Q1 adjusted earnings Wednesday of $1.07 per diluted share, down from $1.09 a year earlier.

Analysts polled by Capital IQ expected $1.06.

Net sales for the quarter ended Aug. 25 were $4.85 billion, down from $4.90 billion a year earlier.

Analysts surveyed by Capital IQ expected $4.80 billion.

General Mills ( GIS ) reiterated its fiscal 2025 adjusted earnings per share outlook of a 1% decline to a 1% increase.

Shares of General Mills ( GIS ) were down more than 1% in recent premarket activity.

Price: 73.50, Change: -1.00, Percent Change: -1.34

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: Edison International Utility Hit With Lawsuit Over Wildfire in Los Angeles
Update: Market Chatter: Edison International Utility Hit With Lawsuit Over Wildfire in Los Angeles
Jan 13, 2025
03:49 PM EST, 01/13/2025 (MT Newswires) -- (Updates with comment from SoCalEd.) Edison International's ( EIX ) southern California utility is facing a lawsuit blaming the company's equipment for igniting a wildfire in Los Angeles, Bloomberg reported Monday. The legal complaint, filed in Los Angeles Superior Court on behalf of the stakeholders with properties damaged by the Eaton Fire, attributed...
GSK Acquiring US-Based IDRx for up to $1.15 Billion
GSK Acquiring US-Based IDRx for up to $1.15 Billion
Jan 13, 2025
03:51 PM EST, 01/13/2025 (MT Newswires) -- GSK (GSK) has agreed to acquire Boston-based IDRx for up to $1.15 billion as the British drugmaker looks to expand its gastrointestinal cancer portfolio, the companies said Monday. IDRx is behind IDRX-42, which is being developed as a first- and second-line therapy to treat gastrointestinal stromal tumors, or GIST. GSK's New York Stock...
Aar Insider Sold Shares Worth $8,573,697, According to a Recent SEC Filing
Aar Insider Sold Shares Worth $8,573,697, According to a Recent SEC Filing
Jan 13, 2025
03:57 PM EST, 01/13/2025 (MT Newswires) -- John McClain Holmes III, Director, Chairman, President & CEO, on January 10, 2025, sold 128,427 shares in Aar (AIR) for $8,573,697. Following the Form 4 filing with the SEC, Holmes has control over a total of 346,680 shares of the company, with 346,680 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1750/000112760225001112/xslF345X05/form4.xml Price: 69.67, Change: +1.95,...
IAC CEO Joey Levin to step down as it spins off home services unit Angi
IAC CEO Joey Levin to step down as it spins off home services unit Angi
Jan 13, 2025
Jan 13 (Reuters) - IAC said on Monday longtime boss Joey Levin will step down as CEO after the spinoff of its majority stake in home services marketplace Angi ( ANGI ) as the media and internet company looks to focus on Dotdash Meredith, its largest business. Levin will make a transition to the role of advisor for IAC and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved